U.S. investors and large pharmaceutical companies are increasingly doing deals in China as the country’s biopharma sector ...
Stifel Financial is a top pick for long-term growth with solid Q424 results, a 10% dividend hike & solid wealth management ...
GATX Corporation (NYSE: GATX) announced the cancellation of its presentation and webcast at the Stifel 2025 Transportation & ...
Stifel Nicolaus analyst Benjamin Burnett maintained a Hold rating on Crispr Therapeutics AG (CRSP – Research Report) today and set a price ...
In a report released today, Brian Butler from Stifel Nicolaus maintained a Buy rating on Casella Waste (CWST – Research Report), with a price ...
MoneyLion operates a “content-as-a-service platform” called mFeed, and Stifel Discover is expected to deliver personalized ...
Onsemi (NASDAQ:ON – Get Free Report) had its price objective reduced by research analysts at Stifel Nicolaus from $60.00 to $52.00 in a research note issued on Tuesday,Benzinga reports. The firm ...
SPS Commerce (NASDAQ:SPSC – Get Free Report) had its price target decreased by analysts at Stifel Nicolaus from $225.00 to $200.00 in a report released on Tuesday,Benzinga reports. The brokerage ...
Stifel analysts lowered their price target for Tesla stock in response to “the negative downturn in consumers' perception of ...
According to Benzinga Pro, Stifel Financial's peer group average for short interest as a percentage of float is 3.37%, which ...
We recently compiled a list of the 10 AI News Updates on Wall Street’s Radar. In this article, we are going to take a look at ...
CEO Jon Congleton highlighted the company's focus on advancing its pivotal trials for lorundrostat, targeting dysregulated aldosterone in patients with uncontrolled and resistant hypertension. He ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results